MAP Pharmaceuticals, Inc. (MAPP) Posts Wider than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts MAPP Hot Sheet
Price: $28.19 --0%
Financial Fact:
Total operating expenses: 13.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total operating expenses: 13.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q1 EPS of ($0.58), $0.19 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.1 million.
For earnings history and earnings-related data on MAP Pharmaceuticals, Inc. (MAPP) click here.
For earnings history and earnings-related data on MAP Pharmaceuticals, Inc. (MAPP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
